Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis: no

Mult Scler. 2015 Feb;21(2):132-3. doi: 10.1177/1352458514565415. Epub 2015 Jan 12.

Author

Jordi Río¹

Affiliation

¹ Centre d'esclerosi múltiple de Catalunya (CEM-Cat), Neurology-Neuroimmunology department, Hospital Universitari Vall d'Hebron, Spain jrio@cem-cat.org.

PMID: 25583834
DOI: 10.1177/1352458514565415

No abstract available

MeSH terms

Biomarkers
Humans
Immunologic Factors / pharmacology*
Magnetic Resonance Imaging
Multiple Sclerosis / diagnosis*
Multiple Sclerosis / drug therapy*
Outcome Assessment, Health Care / standards*
White Matter / pathology*

Substances

Biomarkers
Immunologic Factors